Psychosocial Aspects of Diabetes Technology Use

Barriers to Uptake of Insulin Technologies and Novel Solutions

“…In those utilizing AID systems, some users reported increased anxiety and depressive symptoms, 110 with other studies reporting either no impact on symptoms based on insulin delivery method or a reduction in symptoms when utilizing CSII compared with MDI. 108 , 109 Another study demonstrated an association between higher depressive scores and PwD transitioning from CSII to MDI, but transitioning from MDI to CSII subsequently resulted in a decrease in symptoms. This suggests that increased depressive symptoms may influence PwD to transition their insulin delivery method, regardless of method utilized.…”

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents

“…In addition to surveys, the lived experience of CL can also be obtained through focus groups and/or structured interviews. These experiences often draw out more context to daily use of a CL system and highlight situations that are more or less distressing as well as situations in which CL systems worked (or did not work) well 8,9,15,16 . The combination of the two methods results in a more complete picture of the lived experience of using CL systems in paediatric type 1 diabetes.…”

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

“…Youth with T1D who use insulin pumps tend to experience benefits in health-related quality of life compared to MDI. [240][241][242] Parents may also experience improved quality of life. 243 Specific perceived benefits of pump therapy include increased autonomy in diabetes management, decreased diabetes burdens, and greater flexibility in eating.…”